BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9515828)

  • 1. Short-term growth in asthmatic children using fluticasone propionate.
    Visser MJ; van Aalderen WM; Elliott BM; Odink RJ; Brand PL
    Chest; 1998 Mar; 113(3):584-6. PubMed ID: 9515828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.
    Agertoft L; Pedersen S
    Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
    Wolthers OD; Moore A; Mersmann S; Dissanayake S
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial.
    Wolthers OD; Stone S; Bareille P; Tomkins S; Khindri S
    Clin Ther; 2017 Jun; 39(6):1191-1199. PubMed ID: 28545804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate.
    Wolthers OD; Pedersen S
    Arch Dis Child; 1993 May; 68(5):673-6. PubMed ID: 8323338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
    Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW; Wisniewski A; Honour J; Tattersfield AE
    Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.
    Price JF; Russell G; Hindmarsh PC; Weller P; Heaf DP; Williams J
    Pediatr Pulmonol; 1997 Sep; 24(3):178-86. PubMed ID: 9330414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.
    Allen DB; Bronsky EA; LaForce CF; Nathan RA; Tinkelman DG; Vandewalker ML; Konig P
    J Pediatr; 1998 Mar; 132(3 Pt 1):472-7. PubMed ID: 9544904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
    J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate.
    Wong JY; Zacharin MR; Hocking N; Robinson PJ
    J Paediatr Child Health; 2002 Feb; 38(1):59-62. PubMed ID: 11869402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents.
    Mahajan P; Pearlman D; Okamoto L
    J Allergy Clin Immunol; 1998 Jul; 102(1):19-23. PubMed ID: 9679843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide.
    Acun C; Tomac N; Ermis B; Onk G
    Allergy Asthma Proc; 2005; 26(3):204-6. PubMed ID: 16119035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma.
    Staresinic AG; Sorkness CA
    Expert Opin Pharmacother; 2000 Sep; 1(6):1227-44. PubMed ID: 11249490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition and growth in asthmatic children treated with inhaled steroids.
    Salvatoni A; Nosetti L; Broggini M; Nespoli L
    Ann Allergy Asthma Immunol; 2000 Sep; 85(3):221-6. PubMed ID: 11030277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.
    Bisgaard H; Allen DB; Milanowski J; Kalev I; Willits L; Davies P
    Pediatrics; 2004 Feb; 113(2):e87-94. PubMed ID: 14754977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.